Acute myeloid leukemia pediatric · 3 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
COG AAML1421 protocol N/A - intrathecal component | — | R 21 352 | 28d | — | — | — | — | — |
FLAG Variant #01 | — | R 21 352 | — | — | ~6.7 mo | — | — | 1 |
FLAG-DNX Variant #01 Partial | — | R 21 352 | — | — | — | — | — | — |
3 of 3 regimens shown